Related Experiment Video
Updated: May 5, 2026

A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography HPLC
Published on: March 15, 2017
Glucocapparin variability among four populations ofIsomeris arborea Nutt
M J Blua1, Z Hanscom, B D Collier
1Department of Biology, San Diego State University, 92182-0057, San Diego, California.
Abstract:
Glucocapparin (methylglucosinolate), a putative defense compound, was found to vary between desert and nondesert populations ofIsomeris arborea (Capparaceae): Plants from desert populations contained greater concentrations than nondesert plants in four of the five organs analyzed. Immature leaves at desert sites had average glucocapparin concentrations of 9.2 mg/g and 8.4 mg/g, while nondesert sites averaged 6.0 mg/g and 4.6 mg/g. Mature leaves from desert sites had average concentrations of 12.8 mg/g and 7.9 mg/g; leaves from plants at nondesert sites contained approximately one third to one half of those concentrations. A similar pattern was observed in capsule walls and seeds but not in flower buds; for these, non-desert plants contained a slightly higher concentration of glucocapparin. Our studies show that nitrogen and glucocapparin concentrations fluctuate throughout the year and contribute to the observed variability among populations during any particular season. Glucocapparin may fluctuate seasonally as much as 37% in immature leaves and 78% in mature leaves. In a controlled experiment, glucocapparin concentration varied inversely with nitrogen fertilizer treatment. The plants treated with fertilizer lacking nitrogen ranged from 10.1 mg/g to 10.9 mg/g glucapparin, which was roughly twice the concentration of those supplied with 20 mM nitrogen in the fertilizer.
Related Concept Videos
Genetic Variation
Genes exist in different versions called alleles,...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Bioavailability: Influencing Factors
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

